US drugmaker Pfizer Inc and Ireland-based Allergan Plc walked away from their $160 billion merger on Wednesday, a major win for President Barack Obama, who has been pushing to curb deals in which companies move overseas to save on taxes
Read MoreSome 70 million Indians live with diabetes and half of them are ignorant of their condition, says Sanjiv Agarwal, founder and CEO of Diabetacare
Read MoreOn World Health Day, two disruptive platforms, Practo and Twitter partner to revolutionize healthcare access
Read MorePfizer will have to pay Allergan up to $400 million for its expenses as a result of terminating the deal, according to their merger agreement
Read MoreThe government wants manufacturers to cover 85 per cent of a cigarette pack's surface in health warnings, up from 20 per cent now
Read MoreTB treatment and control programs should focus on accurate and timely diagnosis, identification of clinically appropriate treatment regimens, patient monitoring and follow-up, expert say
Read MoreThe company said it did not expect any disruption to supply from its main manufacturing plant despite what it called minor observations made by the US Food and Drug Administration after an audit
Read MoreThe availability of electronic medical records and the thorough e-documentation of patient-doctor interactions now makes it possible for healthcare companies to analyse more data to improve outcomes
Read More